Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease – despite stricter guidelines that no longer ...

With all the painkillers out there, we sometimes forget one that has been around forever: aspirin! It has been called the ...

Under the terms of the deal, GIC, one of the world’s biggest institutional investors, and healthcare-focused private equity group Linden Capital Partners will buy out a minority stake owned by rival ...

Drug repurposing is undervalued, but it offers potential benefits for patients and healthcare systems, argue Ruth Langley and colleagues Drug repurposing involves finding new indications for ...

Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease—despite stricter ...

Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease – despite stricter ...

Bayer’s AskBio gene therapy unit has started recruiting patients into a phase 2 trial of its AB-1002 candidate for congestive heart failure (CHF), buoyed by encouraging data from a first-in ...

In short, aspirin is no longer seen as a one-size-fits-all answer for heart attack prevention. It can still be life-saving ...

Four years after this P2Y12 inhibitor therapy was associated with a 23% lower risk of an outcome that combined cardiovascular death, heart attack, or stroke, when compared with aspirin.

Bayer BAYRY announced that it has submitted a new drug application (“NDA”) to the FDA seeking approval for its investigational low-dose gadolinium-based contrast agent (“GBCA ...

CHICAGO — Daily adjuvant aspirin did not reduce disease recurrence for patients with colorectal cancer liver metastases and may increase risk for death, according to findings presented at ASCO ...

The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros.